You are here

Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Miami, Florida, 33169 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hepatic Insufficiency
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of reduced hepatic function (Child Pugh Classification A or B)

- Body Mass Index of 18-32 kg/m2

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of febrile illness within 5 days prior to first dose

- Any condition possibly affecting drug absorption (e.g. gastrectomy)

- Positive urine drug screen

NCT00692341
Pfizer
Completed
Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hepatic Insufficiency
NCT00969813
All Genders
18+
Years
South Miami, Florida
Hepatic Insufficiency Healthy
NCT02334800
All Genders
18+
Years
Multiple Sites
Obesity, Hepatic Insufficiency
NCT00645021
All Genders
18+
Years
Multiple Sites
Hepatitis C, Hepatic Insufficiency
NCT00314054
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now